바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.71 No.3
Citation Share

Prediction of Brobchodilator Response by Using FEF_(25∼75%) in Adult Patient with a Normal Spirometry Result

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2011, v.71 no.3, pp.188-194








& (2011). Prediction of Brobchodilator Response by Using FEF_(25∼75%) in Adult Patient with a Normal Spirometry Result. Tuberculosis & Respiratory Diseases, 71(3), 188-194.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: When patients with chronic respiratory symptoms have a normal spirometry result, it is not always easy to consider bronchial asthma as the preferential diagnosis. Forced expiratory flow between 25% and 75% of vital capacity (FEF_(25∼75%)) is known as a useful diagnostic value of small airway diseases. However, it is not commonly used, because of its high individual variability. We evaluated the pattern of bronchodilator responsiveness (BDR) and the correlation between FEF_(25∼75%) and BDR in patients with suspicious asthma and normal spirometry. Methods: Among patients with suspicious bronchial asthma, 440 adult patients with a normal spirometry result (forced expiratory volume in one second [FEV_1]/forced vital capacity [FVC] ≥70% & FEV_1% predicted ≥80%) were enrolled. We divided this group into a positive BDR group (n=43) and negative BDR group (n=397), based on the result of BDR. A comparison was carried out of spirometric parameters with % change of FEV_1 after bronchodilator (ΔFEV_1%). Results: Among the 440 patients with normal spirometry, FEF_(25∼75%)% predicted were negatively correlated with ΔFEV_1% (r=−0.22, p＜0.01), and BDR was positive in 43 patients (9.78%). The means of FEF_(25∼75%)% predicted were 64.0±14.5% in the BDR (＋) group and 72.9±20.8% in the BDR (−) group (p＜0.01). The negative correlation between FEF_(25∼75%)% predicted and ΔFEV_1% was stronger in the BDR (＋) group (r=−0.38, p=0.01) than in the BDR (−) group (r=−0.17, p＜0.01). In the ROC curve analysis, FEF_(25∼75%) at 75% of predicted value had 88.3% sensitivity and 40.3% specificity for detecting a positive BDR. Conclusion: BDR (＋) was not rare in patients with suspicious asthma and normal spirometry. In these patients, FEF_(25∼75%)% predicted was well correlated with BDR.

keywords
Bronchodilator Agents, Asthma, Bronchodilator Agents, Asthma

Reference

1.

1. Kaplan AG, Balter MS, Bell AD, Kim H, McIvor RA. Diagnosis of asthma in adults. CMAJ 2009;181:E210-20.

2.

2. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44-51.

3.

3. Alberts WM, Ferris MC, Brooks SM, Goldman AL. The FEF25-75% and the clinical diagnosis of asthma. Ann Allergy 1994;73:221-5.

4.

4. Lougheed MD, Lemière C, Dell SD, Ducharme FM, Fitzgerald JM, Leigh R, et al. Canadian Thoracic Society Asthma Management Continuum--2010 Consensus summary for children six years of age and over, and adults. Can Respir J 2010;17:15-24.

5.

5. Choi BW, Yoo KH, Jeong JW, Yoon HJ, Kim SH, Park YM, et al. Easy diagnosis of asthma: computer-assisted, symptom-based diagnosis. J Korean Med Sci 2007;22: 832-8.

6.

6. McFadden ER Jr, Linden DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med 1972;52:725-37.

7.

7. Jung SY, Lee ES, Lee YH, Moon HK. Evaluation of the severity in patients with bronchial asthma using FEF25-75%. J Korean Pediatr Soc 2001;44:916-21.

8.

8. Rhee KH, Kim JK, Kim JH, Lim DH, Son BK. Usefulness of FEF25-75% in methacholine bronchial provocation test in children with asthma. Pediatr Allergy Respir Dis 2005;15:408-14.

9.

9. Ciprandi G, Signori A, Tosca MA, Cirillo I. Bronchodilation test in patients with allergic rhinitis. Allergy 2011; 66:694-8.

10.

10. Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF Jr, Szefler SJ, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010;126:527-34.e1-8.

11.

11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.

12.

12. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.

13.

13. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010. GINA; c2010 [cited 2011 Sep 14]. Available from: http://www. ginasthma.org/pdf/GINA_Report_2010.pdf.

14.

14. Sposato B, Mariotta S, Ricci A. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry? J Asthma 2008;45: 479-83.

15.

15. Scichilone N, Battaglia S, Olivieri D, Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Allergy 2009;64: 1563-9.

16.

16. Mariotta S, Sposato B, Ricci A, Bruno P, Aquilini M, Mannino F. Reversibility test in the early stages of bronchial asthma. J Asthma 2005;42:487-91.

17.

17. Gelb AF, Williams AJ, Zamel N. Spirometry. FEV1 vs FEF25-75 percent. Chest 1983;84:473-4.

18.

18. Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest 2006;129:369-77.

19.

19. Bellia V, Cibella F, Cuttitta G, Scichilone N, Mancuso G, Vignola AM, et al. Effect of age upon airway obstruction and reversibility in adult patients with asthma. Chest 1998;114:1336-42.

20.

20. Chotirmall SH, Watts M, Branagan P, Donegan CF, Moore A, McElvaney NG. Diagnosis and management of asthma in older adults. J Am Geriatr Soc 2009;57: 901-9.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy